个体化预康复:改善肝移植候选者衰弱指标与生存的路径
这项双向性队列研究纳入1275例肝移植候选者,由物理治疗师制定个体化预康复方案。结果显示,衰弱指数(LFI)改善至少0.4与死亡风险降低约50%相关(HR=0.56,p=0.037),而6分钟步行试验改善未显示生存优势。
要点
- 个体化预康复可显著改善肝移植候选者的LFI和6分钟步行距离。
- LFI改善至少0.4与死亡风险降低约50%相关(HR=0.56,p=0.037)。
- 6分钟步行试验改善与生存优势无关。
核心结论
- 肝移植候选者接受个体化预康复与LFI和6分钟步行试验的显著改善相关。
- LFI改善至少0.4与生存改善相关,可视为衰弱干预的最小临床重要差异。
研究设计与样本
- 双向性队列研究,纳入1275例肝移植候选者,共1973次肝移植-物理治疗访视。
- 其中355例参加两次及以上随访访视并参与预康复项目。
- 基线时中位LFI为3.8(3.2-4.4),6分钟步行距离为336米(243-403),步速为1米/秒(0.8-1.2)。
主要发现
- 基线时分别有23%、26%、29%的患者按各工具判定为衰弱。
- LFI改善者(226/352)的绝对变化为-0.39(-0.32至-0.46),6分钟步行距离改善者(212/334)的改善为54米(43-64)。
- 不到一半的患者步速测试改善。
- 667例(55%)进入等待名单,462例(37%)接受移植,335例(26%)死亡。
- LFI改善至少0.4与死亡风险降低约50%相关(HR=0.56,p=0.037)。
关键数值与推荐
- LFI改善至少0.4与死亡风险降低约50%相关(HR=0.56,p=0.037)。
- 6分钟步行试验改善与生存优势无关。
临床怎么用
- 对肝移植候选者可考虑由物理治疗师制定个体化预康复方案。
- 可将LFI改善至少0.4作为衰弱干预的最小临床重要差异目标。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Outpatient prehabilitation can potentially improve frailty in liver transplant (LT) candidates. Our aim was to determine the impact of prehabilitation on physical fitness and mortality, and to identify the minimum clinically important change needed to improve survival. METHODS: In this ambispective cohort study, LT candidates underwent baseline evaluation with a dedicated physical therapist (PT) and were prescribed a personalized prehabilitation program based on their functional status. Liver frailty index (LFI), 6-min walk test (6MWT), and gait speed test (GST) were assessed. Multilevel linear mixed-effects models and multivariable survival analyses were fitted, including competing risks models against LT. RESULTS: A total of 1275 patients (59% male, age 57±11, MELD 14±6) attended 1973 LT-PT visits. Of these, 355 attended two or more follow-up visits, participating in the prehabilitation program. At baseline, median LFI was 3.8 (3.2-4.4), 6MWT 336 m (243-403), and GST 1 (0.8-1.2); 23%, 26%, and 29% of the cohort were frail by each tool, respectively. Among subjects who improved LFI (n=226/352), the absolute change was -0.39 (-0.32 to -0.46), and for 6MWT (n=212/334) it was 54 m (43-64); fewer than half improved GST. A total of 667 (55%) patients were waitlisted, 462 (37%) transplanted, and 335 (26%) died. LFI improvement by at least 0.4 was associated with a ∼50% reduction in mortality (HR=0.56, p=0.037). Improvement in 6MWT was not associated with a survival advantage. CONCLUSION: Individualized prehabilitation in LT candidates was associated with significant improvement in LFI and 6MWT. A minimum LFI improvement of 0.4 was associated with improved survival and could be considered a minimal clinically important difference for frailty interventions in LT candidates.
引用
- Lin FP, Bloomer PM, Dunn MA, et al. Personalized Prehabilitation: A Pathway to Improved Frailty Metrics and Survival in Liver Transplant Candidates. Clin Gastroenterol Hepatol. 2026. PMID: 42906873. doi:10.1016/j.cgh.2026.09.044
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。